Spero Reports Preliminary Findings From Phase 1 Clinical Trial Of SPR720; Says First Indication Of Human Safety And PK Profiles Supports Advancement Of Program To Phase 2a PRoof-Of-Concept Trial
Benzinga Newsdesk